Novo Nordisk A/S

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Innate Pharma SA (IPH)

Transaction date 30 May 2025

Proposed sale

Price

355.22

Quantity 67,855

Value US$3,847,995

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2025-05-30	2025-05-30	Innate Pharma SA (IPH)	PrS Proposed sale	67,855 355.22 US$3,847,995	67,855	355.22	US$3,847,995